Literature DB >> 21277306

Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Ann L Oberg1, Neelam Dhiman, Diane E Grill, Jenna E Ryan, Richard B Kennedy, Gregory A Poland.   

Abstract

INTRODUCTION: We sought to determine the time and vaccinia virus dose combination that would maximize the number of acute immune response changes in response to vaccinia stimulation in preparation for a large gene expression microarray experiment.
METHODS: PBMCs from ten subjects were exposed to five vaccinia virus doses for three lengths of time. Gene expression was measured for 90 immune response genes via Taqman® Low Density Immune Arrays. Expression data were normalized via model-based non-linear normalization. Linear mixed effects model results were used to standardize changes across genes and determine the time/multiplicity of infection (MOI) combination with the largest number of changes.
RESULTS: The greatest number of changes occurred with a MOI of 5.0 and exposure time of 48 h. Further inspection revealed that most changes had occurred earlier and faded at this combination. The second highest number of changes was found at a MOI of 0.5 PFU/cell and time of 18 h.
CONCLUSIONS: We conclude a time of 18 h with a MOI of 0.5 PFU/cell is the optimal time/MOI combination for the full scale gene expression study. The strategy described herein is a general and resource efficient way to make critical decisions regarding experimental parameters for studies utilizing expensive assays that interrogate a large number of variables.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277306      PMCID: PMC3051012          DOI: 10.1016/j.jim.2011.01.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  52 in total

1.  A multivariate analysis approach to the integration of proteomic and gene expression data.

Authors:  Ailís Fagan; Aedín C Culhane; Desmond G Higgins
Journal:  Proteomics       Date:  2007-06       Impact factor: 3.984

Review 2.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light.

Authors:  K Tsung; J H Yim; W Marti; R M Buller; J A Norton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

4.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

5.  Transcriptional interactions during smallpox infection and identification of early infection biomarkers.

Authors:  Willy A Valdivia-Granda; Maricel G Kann; Jose Malaga
Journal:  Pac Symp Biocomput       Date:  2007

6.  Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Raquel Conde; Alberto Pascual-Montano; Keith Harshman; Mariano Esteban
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.

Authors:  Jenna E Ryan; Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  J Immunol Methods       Date:  2008-11-25       Impact factor: 2.303

8.  Assessment of real-time RT-PCR for quantification of Lactobacillus plantarum gene expression during stationary phase and nutrient starvation.

Authors:  M L Marco; M Kleerebezem
Journal:  J Appl Microbiol       Date:  2007-12-11       Impact factor: 3.772

9.  PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells.

Authors:  Eva Kriegova; Arsen Arakelyan; Regina Fillerova; Jaromir Zatloukal; Frantisek Mrazek; Zdenka Navratilova; Vitezslav Kolek; Roland M du Bois; Martin Petrek
Journal:  BMC Mol Biol       Date:  2008-07-31       Impact factor: 2.946

10.  Modulation of gene expression in a human cell line caused by poliovirus, vaccinia virus and interferon.

Authors:  Bjørn Grinde; Marc Gayorfar; Gunnar Hoddevik
Journal:  Virol J       Date:  2007-03-05       Impact factor: 4.099

View more
  5 in total

1.  An interaction quantitative trait loci tool implicates epistatic functional variants in an apoptosis pathway in smallpox vaccine eQTL data.

Authors:  C A Lareau; B C White; A L Oberg; R B Kennedy; G A Poland; B A McKinney
Journal:  Genes Immun       Date:  2016-04-07       Impact factor: 2.676

2.  Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Gregory A Poland; Inna G Ovsyannikova; Ann L Oberg; Yan W Asmann; Diane E Grill; Robert A Vierkant; Robert M Jacobson
Journal:  Vaccine       Date:  2016-05-11       Impact factor: 3.641

3.  High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Neelam Dhiman; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2012-09-04       Impact factor: 5.226

4.  Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Sumit Middha; Brian M Bot; Vivian W Wang; David I Smith; Robert M Jacobson; Gregory A Poland
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

5.  Molecular network, pathway, and functional analysis of time-dependent gene changes associated with pancreatic cancer susceptibility to oncolytic vaccinia virotherapy.

Authors:  Dana Haddad; Nicholas Socci; Chun-Hao Chen; Nanhai G Chen; Qian Zhang; Susanne G Carpenter; Arjun Mittra; Aladar A Szalay; Yuman Fong
Journal:  Mol Ther Oncolytics       Date:  2016-03-16       Impact factor: 7.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.